← Latest news 
Sun Pharma wins trademark battle as Bombay High Court blocks rival United Biotech
Economy
Published on 6 May 2026
The court sided with Octride after comparing claims
The Bombay High Court ruled in favour of Sun Pharmaceutical Industries in a trademark dispute against United Biotech. It restrained United Biotech from using a similar mark, holding that Sun Pharma’s “Octride” has the stronger claim. The case relates to drugs used for acromegaly and carcinoid tumours, with the judgment protecting Sun’s reputation and goodwill.
- Bombay High Court ruled for Sun Pharma in the trademark case
- United Biotech was restrained from using a similar trademark
- Court protected Sun Pharma’s “Octride” mark
- Dispute involved treatments for acromegaly and carcinoid tumours
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times